West Pharmaceutical Services Inc (WST)
320.85
-0.03
(-0.01%)
USD |
NYSE |
Nov 22, 14:44
West Pharmaceutical Services Shareholders Equity (Quarterly): 2.752B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.752B |
June 30, 2024 | 2.577B |
March 31, 2024 | 2.681B |
December 31, 2023 | 2.881B |
September 30, 2023 | 2.868B |
June 30, 2023 | 2.747B |
March 31, 2023 | 2.776B |
December 31, 2022 | 2.685B |
September 30, 2022 | 2.471B |
June 30, 2022 | 2.424B |
March 31, 2022 | 2.326B |
December 31, 2021 | 2.335B |
September 30, 2021 | 2.202B |
June 30, 2021 | 2.033B |
March 31, 2021 | 1.829B |
December 31, 2020 | 1.854B |
September 30, 2020 | 1.719B |
June 30, 2020 | 1.606B |
March 31, 2020 | 1.490B |
December 31, 2019 | 1.573B |
September 30, 2019 | 1.488B |
June 30, 2019 | 1.445B |
March 31, 2019 | 1.370B |
December 31, 2018 | 1.396B |
September 30, 2018 | 1.352B |
Date | Value |
---|---|
June 30, 2018 | 1.282B |
March 31, 2018 | 1.305B |
December 31, 2017 | 1.280B |
September 30, 2017 | 1.317B |
June 30, 2017 | 1.242B |
March 31, 2017 | 1.169B |
December 31, 2016 | 1.118B |
September 30, 2016 | 1.142B |
June 30, 2016 | 1.109B |
March 31, 2016 | 1.074B |
December 31, 2015 | 1.024B |
September 30, 2015 | 995.30M |
June 30, 2015 | 989.40M |
March 31, 2015 | 941.10M |
December 31, 2014 | 956.90M |
September 30, 2014 | 970.10M |
June 30, 2014 | 972.60M |
March 31, 2014 | 934.60M |
December 31, 2013 | 906.40M |
September 30, 2013 | 836.70M |
June 30, 2013 | 784.20M |
March 31, 2013 | 745.90M |
December 31, 2012 | 728.90M |
September 30, 2012 | 717.10M |
June 30, 2012 | 679.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.490B
Minimum
Mar 2020
2.881B
Maximum
Dec 2023
2.292B
Average
2.380B
Median
Shareholders Equity (Quarterly) Benchmarks
Repligen Corp | 2.017B |
Perspective Therapeutics Inc | 328.47M |
Retractable Technologies Inc | 83.46M |
Xtant Medical Holdings Inc | 45.72M |
Catheter Precision Inc | 12.83M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.675B |
Total Liabilities (Quarterly) | 923.00M |
Debt to Equity Ratio | 0.0736 |
Current Ratio | 3.002 |
Net Debt Paydown Yield | 0.00% |